The prescribed dosage for Ilaris (canakinumab) may depend on your individual treatment plan. Factors like your medical history and body weight may affect your dosage of Ilaris. Ilaris (canakinumab) is ...

Ilaris (canakinumab) is a prescription drug that’s used to treat certain conditions such as Still disease. Ilaris comes as a liquid solution that a healthcare professional will give as an injection ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Novartis’ Ilaris injection for the treatment of active and adult-onset Still’s disease, ...

Ilaris® (canakinumab) is the first interleukin-1 beta inhibitor for the treatment of SJIA and the only treatment approved specifically for SJIA that is given as a monthly subcutaneous injection(1) In ...

Jazz Pharmaceuticals and PharmaMar’s Zepzelca (lurbinectedin) has been granted accelerated approval for adult patients with metastatic small cell lung cancer (SCLC) whose disease has progressed during ...

Novartis receives EU approval for Ilaris® in patients suffering acute gouty arthritis attacks who cannot gain relief from current treatments Ilaris® is the first biologic approved in the EU for ...

The approval of Ilaris (canakinumab) in the treatment of adult-onset Still's disease (AOSD) brings hope for Canadians living with this rare, debilitating, and sometimes life-threatening inflammatory ...